Fluoxetine and Methyltestosterone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fluoxetine (fluoxetine hydrochloride) and Methyltestosterone (methyltestosterone). Common drug interactions include pain among females and aggression among males.

The phase IV clinical study analyzes what interactions people have when they take Fluoxetine and Methyltestosterone. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Fluoxetine?

Fluoxetine has active ingredients of fluoxetine hydrochloride. It is often used in depression. eHealthMe is studying from 98,823 Fluoxetine users. Check the latest studies of Fluoxetine.

What is Methyltestosterone?

Methyltestosterone has active ingredients of methyltestosterone. eHealthMe is studying from 352 Methyltestosterone users. Check the latest studies of Methyltestosterone.

On Jul, 13, 2026

19 people who take Fluoxetine and Methyltestosterone together, and have interactions are studied.

Fluoxetine and Methyltestosterone drug interactions.

What are the common drug interactions of Fluoxetine and Methyltestosterone, by gender? *:

female:

Pain
Procedural complication
Syncope (loss of consciousness with an inability to maintain postural tone)
Glaucoma (increased fluid pressure in the eye with vision loss)
Hypotension (abnormally low blood pressure)
Influenza
Pneumonia
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Respiratory disorder (respiratory disease)

male:

Aggression
Completed suicide (act of taking one's own life)
Homicide (human killing another human)
Suicide attempt

What are the common drug interactions of Fluoxetine and Methyltestosterone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Aggression
Completed suicide (act of taking one's own life)
Homicide (human killing another human)
Suicide attempt

30-39:

Blindness unilateral
Glaucoma (increased fluid pressure in the eye with vision loss)
Injection site erythema (redness at injection site)
Injection site irritation
Procedural complication
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)

40-49:

Post-menopausal bleeding
Vaginal haemorrhage (vaginal bleeding)

50-59:

Fatigue (feeling of tiredness)
Injection site haemorrhage (bleeding from injection site)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Respiratory disorder (respiratory disease)
Abdominal pain upper
Blood pressure decreased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Dyspepsia (indigestion)
Sinusitis (inflammation of sinus)
Injection site irritation

60+:

n/a

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 15.79%
Immunodeficiency Common Variable: 3 people, 15.79%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 5.26%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.26%
Drowsiness: 1 person, 5.26%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Fluoxetine and Methyltestosterone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously